Your browser doesn't support javascript.
loading
Tracheoesophageal Fistula in a Patient With Advanced NSCLC Who Received Chemoradiotherapy and Ramucirumab.
Abada, Paolo B.
Affiliation
  • Abada PB; Cyramza Product Development, Ramucirumab Global Product Development, Oncology, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana. Electronic address: abada_paolo@lilly.com.
J Thorac Oncol ; 14(1): e19, 2019 01.
Article in En | MEDLINE | ID: mdl-30579552
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tracheoesophageal Fistula / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: J Thorac Oncol Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tracheoesophageal Fistula / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: J Thorac Oncol Year: 2019 Document type: Article Country of publication: United States